Seeing is Knowing
The Power of Cellvizio® Vision
Unlike any other technology in the world, Cellvizio lets you see cells virtually anywhere in the human body at high magnification, in vivo, in real time. Suddenly you can understand what is occurring at the cellular level right now, inside the patient, transforming your approach to diagnosis and treatment.
Discover the Details of
Next-Generation Cellvizio®
Built with enhanced capabilities, this entirely new system uses Confocal Laser Endomicroscopy (CLE) advanced imaging technology to deliver cellular visualization virtually anywhere in the human body. Next-generation Cellvizio pushes the boundaries of interventional medicine, and creates the unique opportunity to accelerate diagnosis, inform treatment, and improve therapy in the diagnosis and care of various diseases and cancers like never before.
Footprint
Easy to maneuver and integrate in the operating room due to its small footprint and slim profile.
Probes
Range of probes for various indications in gastroenterology and pulmonology.
Integration
Picture-in-Picture (PiP) enables optimized integration into endoscopic, bronchoscopic, or operating environments, with DICOM compatibility for patient data retrieval and archiving.
Easy operation
Intuitive and responsive touch-screen interface and single-handed probe connection for quick startup.
Platform
Artificial intelligence (AI)-enabled for assisted image pattern recognition and additional wavelengths and modalities, such as fluorescence-guided surgery.
Mauna Kea Technologies offers service contracts that are tailored to your needs and designed to maintain and ensure continuous support of your Cellvizio system.
Our goal is to optimize the productivity of your system to ensure a continuity of care to your patients.
Confocal Imaging
Cellvizio Images come from a thin focal plane that is optically projected into the tissue. This provides a deep observation of the mucosa and what is happening in the cells in real time.
THE POWER OF CELLVIZIO VISION
Current diagnostic and treatment methods for many serious diseases are invasive, inefficient, and often uncertain. The result is missed diagnoses, unnecessary interventions, and undue complications. Cellvizio changes all that, with powerful impacts for physicians, practices, and patients, across the care continuum.
Transforming a Range of Specialties
By combining extreme clarity of visualization, in vivo information, and flexibility in form and function, Cellvizio is creating exciting new possibilities in diverse medical specialties throughout the body.
PULMONOLOGY
Cellvizio is a game-changing tool for the detection, diagnosis, and treatment of a range of pulmonary disease, and can play a crucial role in understanding the pathogenesis of COVID-19.
GASTROENTEROLOGY
Cellvizio is helping eliminate diagnostic and treatment uncertainty, earlier on the care path, for GI conditions from pancreatic cysts to esophageal and gastric cancers, to inflammatory bowel disease.
UROLOGY
Cellvizio allows real-time visualization of the internal microstructures of tissues in ureteroscopic and cystoscopic procedures, with important diagnostic and therapeutic impacts.
CELLVIZIO IN ENDOSCOPIC PROCEDURES
1
During an endoscopic procedure an area of interest is identified. Cellvizio Confocal Miniprobe™ is inserted into the operating channel of a standard endoscope
2
The miniprobe appears on the endoscopic image and is positioned in contact with the tissue
3
Unlike traditional endoscopy, Cellvizio Confocal Miniprobes provide deep observation of the mucosa at a preferred layer for cancerous tumors
DOWNLOAD THE CELLVIZIO BROCHURE
Disclaimer
Cellvizio® I.V.E. with Confocal MiniprobesTM are regulated Medical Devices, CE marked (CE 0459) (Class IIa – NB :G-MED) and FDA cleared. Cellvizio® is a registered trademark and Confocal MiniprobeTM is a trademark of Mauna Kea Technologies. Cellvizio® I.V.E. with Confocal MiniprobesTM are confocal laser systems with fiber optic probes that are intended to allow imaging of the internal microstructure of tissues including, but not limited to, the identification of cells and vessels and their organization or architecture. These statements and the associated reference to specific clinical studies, are not intended to represent claims of safety or effectiveness for detecting or treating any specific condition or disease state. Rather this information is intended to provide useful reference to selected published literature describing physician experiences with the associated clinical uses. Any diagnostic assessment should always be made by the attending physician, based on the evaluation of all sources of clinical, endoscopic and other relevant information. These statements have not been reviewed, cleared, or approved by the U.S. FDA. The use of this medical device is exclusively reserved for healthcare professionals.
News
YOU MIGHT ALSO LIKE TO READ
Mauna Kea Technologies Announces New Positive Clinical Results for Cellvizio in Food Intolerance
Mauna Kea Technologies Reports H1 2024 Financial Results and Q3 2024 Sales
Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio
Cellvizio Product Brochure
Cellvizio, the real-time in vivo cellular imaging platform, uniquely delivers in vivo cellular visualization which enables physicians to:
Cellvizio is a game-changing tool for the detection, diagnosis, and treatment of a range of pulmonary disease, and can play a crucial role in understanding the pathogenesis of COVID-19.
- Monitor the progression of disease over time
- Assess point-in-time reactions as they happen in real-time
- Classify indeterminate areas of concern
- Guide surgical interventions
The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative change in medicine, download the cellvizio brochure to learn more: